Inmed Pharmaceuticals In (IN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,497 | 5,793 | 6,971 | 9,146 | 11,111 |
| Marketable Securities | 43 | 42 | 41 | 45 | 44 |
| Receivables | 52 | 45 | 32 | 65 | 30 |
| TOTAL | $5,117 | $6,299 | $7,229 | $9,472 | $11,373 |
| Non-Current Assets | |||||
| PPE Net | 385 | 403 | 414 | 470 | 489 |
| Intangibles | 1,089 | 799 | 786 | 870 | 876 |
| Other Non-Current Assets | 14 | 0 | 0 | 0 | 0 |
| TOTAL | $1,487 | $1,202 | $1,200 | $1,340 | $1,365 |
| Total Assets | $6,604 | $7,500 | $8,429 | $10,812 | $12,738 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 71 |
| Accounts payable and accrued liabilities | 153 | N/A | 1,311 | 1,197 | 1,033 |
| Accrued Expenses | 995 | N/A | N/A | N/A | N/A |
| TOTAL | $1,874 | $1,673 | $1,376 | $1,269 | $1,104 |
| Non-Current Liabilities | |||||
| TOTAL | $236 | $247 | $257 | $296 | $310 |
| Total Liabilities | $2,110 | $1,920 | $1,633 | $1,564 | $1,414 |
| Shareholders' Equity | |||||
| Common Shares | 53,065 | 50,212 | 48,357 | 52,501 | 51,805 |
| Retained earnings | -66,248 | -55,958 | -52,259 | -54,589 | -51,712 |
| Other shareholders' equity | -172 | 0 | 0 | 0 | 0 |
| TOTAL | $4,494 | $5,580 | $6,796 | $9,248 | $11,324 |
| Total Liabilities And Equity | $6,604 | $7,500 | $8,429 | $10,812 | $12,738 |